Understanding Translation from Preclinical Models to Clinical Outcomes for Novel Linker-Payload ADC Platforms
- Attenuating payload platform toxicities through novel linker design
- Case studies for translatability of glucuronide linker ADC design with different payload classes
- Challenges of ADC toxicity assessment for linker-payloads with novel mechanisms of action